Allergan Inc. (NYSE: AGN) has completed its $370 million cash acquisition of Esprit Pharma Inc., an East Brunswick, N.J.
Allergan Inc. (NYSE: AGN) has completed its $370 million cash acquisition of Esprit Pharma Inc., an East Brunswick, N.J.
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.